Karuna Therapeutics, Inc. (NASDAQ:KRTX) Shares Sold by Hamilton Lane Advisors LLC

Hamilton Lane Advisors LLC reduced its stake in Karuna Therapeutics, Inc. (NASDAQ:KRTX – Get Rating) by 17.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 64,090 shares of the company’s stock after selling 13,196 shares during the period. Karuna Therapeutics accounts […]

Related Keywords

Hong Kong ,Boston ,Massachusetts ,United States ,Andrew Craig Miller ,Peter Jeffrey Conn ,Stephenk Brannan ,Eric Elenko ,Andrew Miller ,Securities Exchange Commission ,Almanack Investment Partners ,Cantor Fitzgerald ,Karuna Therapeutics Inc ,Advisors Inc ,Nasdaq ,Hong Kong Ltd ,Hamilton Lane Advisors ,Karuna Therapeutics ,Get Rating ,Lane Advisors ,Investment Partners ,Kong Ltd ,Craig Miller ,Visit Holdingschannel ,Karuna Therapeutics Daily ,Nasdaq Krtx ,Krtx ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,